King's College London

Research portal

Dr Cristina Legido Quigley

Biographical details

 
  • The Clinical Biomarkers lab has been based in KCL 11 years, headed by Dr Legido-Quigley the lab is equiped with HPLC-UV, UPLC-q-ToF and GC-MS for chemical analysis and fingerprinting. Funding for biomarker research is secured via goverment allocated research funding (US, China, Saudi, Libya), EU funded collaborative projects with both academic and industry partners (EMIF-AD), UK goverment funding (MRC-NIHR National Phenome Center) and major charities funding research (Alzheimer's Association, ARUK, ROTRF).
  • Collaborations and clinical projects are to do with discovering small molecule biomarkers in clinical fields, to find early diagnosis or biochemical pathways that are implicated in the disease progressing. Also called metabolomics this technology is combined with other -omics to extract information on disease mechanisms. Current projects are to do with Alzheimer's disease and dementia, schizophrenia, Parkinson's, nanomedicine, transplantation, metabolic doping and regeneration, herbal medicine activity.
  • In 2017 the clinical biomarkers lab includes: a PI, 6 PhDs, 4 PGs, a PDRA, a senior ARUK fellow.
  • Dr. Legido-Quigley is MSc programme director and teaches Analytical Chemistry in the IPS, King's College London.

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454